FMP
Evolus, Inc.
EOLS
NASDAQ
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
10.85 USD
0.01 (0.09217%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Mr. David Moatazedi
sector
Healthcare
industry
Drug Manufacturers - Specialty & Generic
website
https://www.evolus.comexchange
NASDAQ
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
CIK
0001570562
ISIN
US30052C1071
CUSIP
30052C107
Address
520 Newport Center Drive
Phone
949 284 4555
Country
US
Employee
322
IPO Date
Feb 8, 2018
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
EOLS Financial Summary
CIK
0001570562
Exchange
NASDAQ
Industry
Drug Manufacturers -...
Sector
Healthcare
CUSIP
30052C107
ISIN
US30052C1071
Country
US
Price
10.85
Beta
1.31
Volume Avg.
605.53k
Market Cap
687.04M
Shares
-
52-Week
9.8-17.82
DCF
-0.05
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-11.92
P/B
-
Website
https://www.evolus.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest EOLS News
It looks like there's no news available.
